North China Pharmaceutical Company.Ltd (SHA:600812)
China
· Delayed Price · Currency is CNY 5.81
-0.20 (-3.33%)
Mar 10, 2026, 11:30 AM CST
SHA:600812 Revenue
North China Pharmaceutical Company.Ltd had revenue of 2.21B CNY in the quarter ending September 30, 2025, a decrease of -5.12%. This brings the company's revenue in the last twelve months to 9.79B, up 0.91% year-over-year. In the year 2024, North China Pharmaceutical Company.Ltd had annual revenue of 9.87B, down -2.48%.
Revenue (ttm)
9.79B
Revenue Growth
+0.91%
P/S Ratio
1.05
Revenue / Employee
970.87K
Employees
10,000
Market Cap
10.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.87B | -250.63M | -2.48% |
| Dec 31, 2023 | 10.12B | -379.75M | -3.62% |
| Dec 31, 2022 | 10.50B | 115.37M | 1.11% |
| Dec 31, 2021 | 10.38B | -1.11B | -9.64% |
| Dec 31, 2020 | 11.49B | 35.02M | 0.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Yahong Meditech | 277.12M |
| Changzhou Qianhong Biopharma CO.,LTD | 1.53B |
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.04B |
| Shandong Lukang Pharmaceutical | 6.19B |
| KPC Pharmaceuticals,Inc. | 6.58B |
| Zhejiang Xianju Pharmaceutical | 3.59B |
| Shenzhen Neptunus Bioengineering | 27.28B |
| Harbin Pharmaceutical Group | 15.94B |